Sox2, which is a ubiquitously expressed transcription factor in cancer stem cells, has a direct effect on the immunosuppressive capacity of GSCs through induction of CD39 (ENTPD1), an ectonucleotidase responsible for hydrolyzing ATP towards adenosine and a critical mediator of immune response in cancer (70, 71). The gene discussed is SOX2; the disease is cancer.